09/06/2019 11:32 AM EDT |
 |
Pre-clinical radiotracer biomedical research involves the use of compounds labeled with radioisotopes, including radio-ligand bio-distribution studies, cell binding studies, immune cell labeling techniques, and α-based therapies. Before this Micro-Dose Calibrator, measurement of pre-clinical level dosage for small animal studies was inaccurate and unreliable. This dose calibrator is a prototype ready for manufacturing. It is designed to accurately measure radioactive doses in the range of 50 nCi (1.8 kBq) to 100 µCi (3.7 MBq) with 1% precision. If you are interested in licensing or collaborative development of this technology, please contact: John Hewes, Ph.D. NCI Technology Transfer Center 240-276-5515 John.Hewes@nih.gov techtransfer.cancer.gov/ www.cancer.gov/news-events/ |
International Journal for Equity in Health
Hace 18 horas
No hay comentarios:
Publicar un comentario